Summary
Overview
Work History
Education
Skills
Patents
Network
Tel
Personal Information
Awards
Timeline
Generic

Cheryl A. Rogers Ph.D.

San Diego,CA

Summary

Strategic and Creative Scientific Business leader with Particular Strengths in Aligning Business Partners and investors with early stage companies. Methodical Director with 15+ years of comprehensive experience developing and overseeing effective innovation programs for the Government of Canada. Hardworking and versatile professional well-versed in advising biotech CEOs in the execution of business strategies, preparing and implementing business plans and raising venture capital. Thorough knowledge of market changes and trends paired with strong grasp of scientific research, biotech finance, FDA regulations and Clinical trials. Business-minded professional tackling any job task with strategic precision. Results-driven program creator, skilled in developing lasting client rapport based on knowledgeable support and consistent service. Demonstrated success in building networks and supporting client's investment and partnering objectives.

Overview

20
20
years of professional experience
40
40
years of post-secondary education

Work History

Sr. International Business Development Director-Life Sciences

Consulate of Canada
San Diego
08.2006 - 08.2023
  • Highly visible role, serving as a senior business development officer responsible for facilitating cross-border industry partnerships, venture investment, and academic collaborations in Canada’s emerging biotechnology sector
  • Targeting business partners, building and managing both academic partnerships with Canadian (CDN) University research labs and tech transfer offices, and improving corporate strategies and investment pitches with prospective biotech industry executives.
  • Designed highly intensive mentorship programs for Canadian biotech start-ups, strategically aligning early-stage assets with pharmaceutical partners, angel investors and venture capital.
  • Identified key business development leads resulting in mutually beneficial business opportunities for Canadian life science companies.
  • Cultivated and maintained high level international relationships and referral network to maximize business sales opportunities
  • Promoted Canadian academic science, drug development, medical devices and manufacturing as well as clinical research capabilities and services.
  • Launched large collaborations of cross-border academic 'Dream Teams' to help solve unmet medical needs in cancer, neuroscience and the human microbiome.
  • Developed a solid relationship with pharmaceutical scouts and venture capital firms to gain partnerships and funding for Canadian Research Institutes and Biotech companies
  • Drafted market reports on industry trends and opportunities in the US Biotechnology and Medical Device/Diagnostic industry
  • Established Canada's key high intensity business advisory programs to provide customized extended support to over 60+ companies, with intensive services leading to successful milestones, several have gone on to collectively raise over $900 Million USD in Venture Capital and Corporate Partnerships.
  • Delivered programs with CDN technology transfer offices that led to 18+ pharmaceutical partnerships
  • Acted as a strategic asset to the Consulate, initiating and establishing several novel cross-border initiatives and agreements including the following areas; California-Canada Strategic partnerships in Cancer Stem Cells, Infectious Diseases, Neurodegenerative Diseases & Alzheimer's while expanding existing relationships in the USA.
  • Expanded Market Footprint in California and Arizona to maximize business opportunities for Canadian companies
  • Designed, coordinated and communicated Canada's international strategy at key conferences. Developed strong internal relationships across the Government of Canada network in order to effectively manage projects from conception to completion.
  • Hosted Canada's 200+ delegates and institutes, officials, and biotechs both virtually and in-person during major industry events, partnering with life science institutes and organizations to leverage established contacts within the industry and cultivate new ones with partners, researchers and other stakeholders from around the globe
  • Significantly raised awareness and visibility of Canada’s Biotech sector at International Biotech Conventions (BIO2008, BIO2014, BIO2017, BIO2020) and local events (BIOCOM Global Life Science Partnering 2010-2023).

Director -Neurodegenerative Diseases/Ophthalmology

Immusol Inc.
San Diego
01.2004 - 01.2006
  • Directed Research teams to position Immusol as an industry leader in the Neurodegeneraton and Age-Related Macular Degeneration
  • Presented data at international meetings, and reported weekly progress to the Chief Scientific Officer
  • Built an Effective Research team and trained postdoctoral and technical staff in various roles, to accomplish company objectives
  • Worked closely with patent attorney to position assets and led presentation for out-licensing to pharmaceutical scouts
  • Fostered, developed, and maintained strategic partnerships internally and externally to move projects forward, while maintaining commitment to organizational priorities around agreed milestones, delivery and impact
  • Planned new experimental models and contributed to novel approaches, solutions and patentable ideas
  • Wrote final reports of projects for out-licensing
  • Successfully directed research that had both relevance and potential impact in strategic areas, including neurodegenerative, ophthalmology, and collaborated with other departments on strategies for infectious diseases
  • Demonstrated excellent data and quality management, and broad scientific knowledge in laboratory operations, as well as identification of allied strategic activities.
  • Worked effectively in fast-paced environments.

Principal Research Scientist

Immusol, Inc.
San Diego, CA
01.2002 - 01.2004
  • Led an interdisciplinary team of six scientists that identified 45 oncology drug targets, advancing Immusol's corporate objectives and partnerships with large pharmaceutical companies.
  • Formulated program plans, developed goals and objectives, directed laboratory research, and evaluated and interpreted results
  • Established an Immuno-histochemistry core group, including localization of company antibody target molecules in normal and cancerous human tissues and cell cultures
  • Managed complex scientific research/development programs and coordinated activities across Immusol's various departments.
  • Presented weekly research team results to the Vice President of Drug Development and Chief Scientific Officer.

Postdoctoral Fellow, Molecular Neurobiology Laboratory

Salk Institute
La Jolla, CA
01.1993 - 01.2002
  • Initiated and established the Ion Channel-Protein Interaction Project in the laboratory of Dr S. Heinemann and collaborated closely with other members of Salk Institute
  • Identified nine novel protein interactions involving NMDA, AMPA, and Kainate receptors
  • Authored and published manuscripts in high impact journals , such as Science magazine etc.
  • Presented research discoveries at International Conferences

Education

BSc. Biological Sciences -

University of Guelph
09.1983 - 06.1987

MSc Anatomy -

University of Ottawa
09.1987 - 12.1989

Ph.D. Physiology -

University of Ottawa
01.1990 - 06.2024

Skills

  • Client & Partner Strategic Relationship Management
  • Team Leadership & Development
  • Business Planning
  • Project Coordination
  • Operations Management
  • Business Development
  • Budget Management
  • Team Management
  • Investor Relations
  • Cross-Functional Team Leadership
  • Corporate Communications
  • Investor & Partnership Pitching
  • International Business
  • Strategic Planning
  • Creativity and Innovation

Patents

  • Compositions and methods for identifying agents useful for the treatment of neurodegenerative diseases, Immusol (2005)
  • Methods of identifying agents that inhibit the growth of cancer cells, Immusol (2003)
  • Methods for Modulating Long Term Potentiation, Salk Institute (2002)

Network

  • CEO’s
  • Chief Scientific Officers
  • Pharmaceutical Scouts
  • Venture Capital Firms
  • Academic Knowledge Leaders

Tel

1-(858)-213-4345

Personal Information

Title: Business Development Professional

Awards

  • Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award (1998-2000)
  • Medical Research Council of Canada Fellowship (1995-1997)
  • Heart and Stroke Foundation of Canada Fellowship (1993-1995)
  • Canadian Heart and Stroke Foundation Pre-Doctoral Scholarship (1990-1993)
  • University of Ottawa Taichman Award for Excellence (1990)
  • University of Ottawa Merit Scholarship (1987-1989)

Timeline

Sr. International Business Development Director-Life Sciences

Consulate of Canada
08.2006 - 08.2023

Director -Neurodegenerative Diseases/Ophthalmology

Immusol Inc.
01.2004 - 01.2006

Principal Research Scientist

Immusol, Inc.
01.2002 - 01.2004

Postdoctoral Fellow, Molecular Neurobiology Laboratory

Salk Institute
01.1993 - 01.2002

Ph.D. Physiology -

University of Ottawa
01.1990 - 06.2024

MSc Anatomy -

University of Ottawa
09.1987 - 12.1989

BSc. Biological Sciences -

University of Guelph
09.1983 - 06.1987
Cheryl A. Rogers Ph.D.